![](/images/graphics-bg.png)
The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro
المؤلفون المشاركون
Yang, Chen
Gao, Chenlin
Yan, Pijun
Peng, Juan
Gou, Fang
Nan, Qinling
Xu, Yong
Chen, Guo
Huang, Wei
Feng, Hong
Zhang, Zhihong
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-11، 11ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-06-09
دولة النشر
مصر
عدد الصفحات
11
التخصصات الرئيسية
الملخص EN
Transforming growth factor-β (TGF-β) has been shown to be involved in diabetic nephropathy (DN).
The SnoN protein can regulate TGF-β signaling through interaction with Smad proteins.
Recent studies have shown that SnoN is mainly degraded by the ubiquitin-proteasome pathway.
However, the role of SnoN in the regulation of TGF-β/Smad signaling in DN is still unclear.
In this study, diabetic rats were randomly divided into a diabetic control group (DC group) and a proteasome inhibitor (MG132) diabetes therapy group (DT group).
Kidney damage parameters and the expression of SnoN, Smurf2, and TGF-β were observed.
Simultaneously, we cultured rat glomerular mesangial cells (GMCs) stimulated with high glucose, and SnoN and Arkadia expression were measured.
Results demonstrated that 24-hour urine protein, ACR, BUN, and the expression of Smurf2 and TGF-β were significantly increased (P<0.05), whereas SnoN was significantly decreased in the DC group (P<0.05).
However, these changes diminished after treatment with MG132.
SnoN expression in GMCs decreased significantly (P<0.05), but Arkadia expression gradually increased due to high glucose stimulation (P<0.05), which could be almost completely reversed by MG132 (P<0.05).
The present results support the hypothesis that MG132 may alleviate kidney damage by inhibiting SnoN degradation and TGF-β activation, suggesting that the ubiquitin-proteasome pathway may become a new therapeutic target for DN.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Huang, Wei& Yang, Chen& Nan, Qinling& Gao, Chenlin& Feng, Hong& Gou, Fang…[et al.]. 2014. The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro. BioMed Research International،Vol. 2014, no. 2014, pp.1-11.
https://search.emarefa.net/detail/BIM-490384
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Huang, Wei…[et al.]. The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro. BioMed Research International No. 2014 (2014), pp.1-11.
https://search.emarefa.net/detail/BIM-490384
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Huang, Wei& Yang, Chen& Nan, Qinling& Gao, Chenlin& Feng, Hong& Gou, Fang…[et al.]. The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-11.
https://search.emarefa.net/detail/BIM-490384
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-490384
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)